Ifenprodil tartrate treatment of adolescents with post-traumatic stress disorder: A double-blind, placebo-controlled trial
Ifenprodil tartrate treatment of adolescents with post-traumatic stress disorder: A double-blind, placebo-controlled trial
复制标题
酒石酸艾芬地尔治疗患有创伤后应激障碍的青少年:一项双盲、安慰剂对照试验
DOI:
10.1016/j.psychres.2022.114486
复制
发表时间:
2022
影响因子:
11.3
通讯作者:
Iyo Masaomi
中科院分区:
文献类型:
--
作者:
Sasaki Tsuyoshi;Hashimoto Kenji;Niitsu Tomihisa;Hosoda Yutaka;Oda Yasunori;Shiko Yuki;Ozawa Yoshihito;Kawasaki Yohei;Kanahara Nobuhisa;Shiina Akihiro;Hashimoto Tasuku;Suzuki Takaaki;Sugawara Takeshi;Hanaoka Hideki;Iyo Masaomi
BackgroundSeveral lines of evidence suggest that glutamatergic neurotransmission via the N-methyl-D-aspartate (NMDA) receptor plays a role in certain behavioral manifestations common to Post-Traumatic Stress Disorder (PTSD). Ifenprodil tartrate is a neuroprotective agent that binds to the GluN2B subunit of the NMDA receptor. The aim of this study is to confirm whether ifenprodil tartrate is effective in the adolescent PTSD patients.MethodsThis is a randomized, double-blind, placebo‐controlled trial. Ten adolescent (13 to 18 years old) PTSD patients were randomized into two arms: placebo (n= 4), 40 mg/day ifenprodil tartrate (n= 6) for 4 weeks. All of the patients were assessed by IES-R-J (Primary outcome measure), TSCC-J, CDRS-R, DSRS-C-J and CGI-I.ResultsA comparison of baseline IES-R-J total scores and 4-week end-point scores showed a mild trend of improvement (p= 0.0895) and the difference score was -9.314. A comparison of baseline scores and 2-week intermediate-point scores showed that IES-R-J hyperarousal subscores and TSCC-J subscores (dissociation subscores, sexual concerns subscores) improved significantly. A comparison of baseline TSCC-J sexual concerns subscores and 4-week end-point scores improved significantly.ConclusionsOur study may prove to be an short-term effective alternative safe treatment for adolescent patients with PTSD.